Antiapoptotic BCL-2 Proteins Determine sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma

Usted está aquí

Home » Publications » Antiapoptotic BCL-2 Proteins Determine sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma

Antiapoptotic BCL-2 Proteins Determine sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma

Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, de Frutos PG, Reig M, Fernandez-Checa JC, Marí M, Colell A, Bruix J, Morales A.,
2018
Referencias: 
Oncotarget. 2018 Mar 30;9(24):16701-16717. doi: 10.18632/oncotarget.24673.